Statistics in Medicine

Article	Citations
	373
Issue Information	131
Issue Information	85
Issue Information	79
	56
	49
Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies	48
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior	44
	44
	44
Optimal confidence intervals for the relative risk and odds ratio	42
Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model	40
Robustness of κ‐type coefficients for clinical agreement	40
Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures	38
Real time monitoring and prediction of time to endpoint maturation in clinical trials	36
Estimands for factorial trials	35
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs	34
Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm	33
Synthesizing studies for comparing different treatment sequences in clinical trials	32
Network and covariate adjusted response‐adaptive design for binary response	31
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study	30
Data fusion for predicting long‐term program impacts	30
Bayesian mixture modelling with ranked set samples	28
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index	27
Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model	27

Improving main analysis by borrowing information from auxiliary data	26
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances	25
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study	23
BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints	22
Discussion on “Is group testing ready for prime‐time in disease identification”	22
Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach	21
Transportability of model‐based estimands in evidence synthesis	21
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule	20
Bayesian additive regression trees for multivariate skewed responses	20
A simulation study of disaggregation regression for spatial disease mapping	20
The Whys, Whens, and Hows of Futility Monitoring	20
The polytomous discrimination index for prediction involving multistate processes under intermittent observation	20
Dynamic Single‐Index Scalar‐On‐Function Model	19
Correction to “A Comparison of Methods to Adjust Survival Curves for Confounders”	19
Multi‐Study Factor Regression Model: An Application in Nutritional Epidemiology	18
On the parameter estimation of Box‐Cox transformation cure model	18
Bayesian model‐averaged meta‐analysis in medicine	18
Incorporating survival data into case‐control studies with incident and prevalent cases	18
Issue Information	17
Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models	17
Regression Trees With Fused Leaves	17
	16
Estimating contact network properties by integrating multiple data sources associated with infectious diseases	16
A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries	16
Model‐assisted analyses of longitudinal, ordinal outcomes with absorbing states	16
Weighted McNemar's test for the comparison of two screening tests in the presence of verification bias	16
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival	16
Multiple multi‐sample testing under arbitrary covariance dependency	16
Relative sparsity for medical decision problems	15
Instrumental variable model average with applications in Mendelian randomization	15
Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data	15
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults	14
A combined multilevel factor analysis and covariance regression model with mixed effects in the mean and variance structure	14
Sensitivity analysis of G‐estimators to invalid instrumental variables	14
Covariate adjustment in randomized clinical trials with missing covariate and outcome data	14
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies	13
Information‐incorporated sparse hierarchical cancer heterogeneity analysis	13
Modeling intra‐individual inter‐trial EEG response variability in autism	13
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart	13
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine	13
A multivariate statistical approach to predict COVID‐19 count data with epidemiological interpretation and uncertainty quantification	13
Bayesian semiparametric joint modeling of longitudinal explanatory variables of mixed types and a binary outcome	13
Finding the best subgroup with differential treatment effect with multiple outcomes	13
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome	13
Nonparametric empirical Bayes biomarker imputation and estimation	13
Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model	13
A systematic review and evaluation of statistical methods for group variable selection	13
A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system	12
IDNetwork: A deep illness‐death network based on multi‐state event history process for disease prognostication	12
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline	12

Adjusted Nelson–Aalen Estimators by Inverse Treatment Probability Weighting With an Estimated Propensity Score	12
Optimal adaptive allocation using deep reinforcement learning in a dose‐response study	12
A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments	12
Standardization and other approaches to meta‐analyze differences in means	12
Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment	12
Variable selection for censored data using Modified Correlation Adjusted coRrelation (MCAR) scores	12
Multilevel Longitudinal Functional Principal Component Model	12
Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies	12
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight	12
A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine	11
Issue Information	11
	11
Joint regression modelling of intensity and timing of accelerometer counts	11
	11
	11
Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions	11
Obituary: Anthony Leonard Johnson (1943‐2022)	11
Issue Information	11
	11
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome	11
Bayesian sensitivity analyses for longitudinal data with dropouts that are potentially missing not at random: A high dimensional pattern‐mixture model	10
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis	10
Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations	10
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model	10
Group sequential designs for clinical trials when the maximum sample size is uncertain	10
Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067	10
Optimal weighted Bonferroni tests and their graphical extensions	10
Local false discovery rate estimation with competition‐based procedures for variable selection	10
Leveraging real‐world evidence for determining performance goals for medical device studies	10
A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data	10
Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules	10
Flexible propensity score estimation strategies for clustered data in observational studies	10
Modeling conditional reference regions: Application to glycemic markers	10
Handling missing within‐study correlations in the evaluation of surrogate endpoints	10
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial	10
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation	10
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity	10
Propensity score analysis with local balance	9
Penalized smoothing splines resolve the curvature identifiability problem in age‐period‐cohort models with unequal intervals	9
Issue Information	9
New methods for multiple testing in permutation inference for the general linear model	9
The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows	9
Distribution‐free model selection for longitudinal zero‐inflated count data with missing responses and covariates	9
Structured time‐dependent inverse regression (STIR)	9
A non‐parametric Bayesian approach for adjusting partial compliance in sequential decision making	9
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome	9
Using fractional polynomials and restricted cubic splines to model non‐proportional hazards or time‐varying covariate effects in the Cox regression model	9
A tractable Bayesian joint model for longitudinal and survival data	9
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies	9
Flexible template matching for observational study design	9
Issue Information	9
Association analysis of self‐reported outcomes with a validated subset	9
Complex survival trial design by the product integration method	9
Correction to “Using principal stratification in analysis of clinical trials”	9
	9
Issue Information	8
	8
Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation	8
Peter Armitage speaking on the occasion of the 50th Anniversary of the M.Sc. in Medical Statistics, LSHTM (for the Symposium on April 11‐12, 2019)	8
Issue Information	8
Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model	8
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards	8
On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection	8
	8
Robust inference for causal mediation analysis of recurrent event data	8
Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures	8
	8
The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints	8
A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases	8
Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies	8
A function‐based approach to model the measurement error in wearable devices	8
Issue Information	8
Issue Information	8
Issue Information	8
	8
A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time	8
Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data	8
A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data	8
Mixed‐type multivariate response regression with covariance estimation	8
Minimization in randomized clinical trials	7

	7
A penalization approach to random‐effects meta‐analysis	7
Multi‐threshold proportional hazards model and subgroup identification	7
Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator‐outcome confounding and intermediate confounding	7
Sample size determination for prediction models via learning‐type curves	7
Comparing the sensitivities of two screening tests in nonblinded randomized paired screen‐positive trials with differential screening uptake	7
Depthgram: Visualizing outliers in high‐dimensional functional data with application to fMRI data exploration	7
An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis	7
Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)	7
Sample size adaptations and evaluation of pediatric study interpretability	7
A sequential, multiple assignment, randomized trial design with a tailoring function	7
Statistical inference for time‐to‐event data in non‐randomized cohorts with selective attrition	7
Confidence intervals for odds ratio from multistage randomized phase II trials	7
Split and combine simulation extrapolation algorithm to correct geocoding coarsening of built environment exposures	7
Saddlepoint approximations to score test statistics in logistic regression for analyzing genome‐wide association studies	7
A classification for complex imbalanced data in disease screening and early diagnosis	7
A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies	7
Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints	7
Weighted generalized estimating equations and unified estimation for longitudinal data with nonmonotone missing data patterns	7
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths	7
MERIT: Controlling Monte‐Carlo error rate in large‐scale Monte‐Carlo hypothesis testing	7
Causal inference methods for vaccine sieve analysis with effect modification	7
Robust structured heterogeneity analysis approach for high‐dimensional data	7
Federated causal inference in heterogeneous observational data	7
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs	6
Survival mediation analysis with the death‐truncated mediator: The completeness of the survival mediation parameter	6
Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference	6
	6
Low‐rank latent matrix‐factor prediction modeling for generalized high‐dimensional matrix‐variate regression	6
Set‐regression with applications to subgroup analysis	6
Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial	6
Fitting a stochastic model of intensive care occupancy to noisy hospitalization time series during the COVID‐19 pandemic	6
A comparison of different methods to adjust survival curves for confounders	6
Optimal allocation in stratified cluster‐based outcome‐dependent sampling designs	6
Assessing heterogeneity in surrogacy using censored data	6
Fast estimation of mixed‐effects location‐scale regression models	6
Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks	6
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data	6
Accounting for publication bias using a bivariate trim and fill meta‐analysis procedure	6
Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models	6
Using population crossover trials to improve the decision process regarding treatment individualization in N‐of‐1 trials	6
A Novel Bayesian Spatio‐Temporal Surveillance Metric to Predict Emerging Infectious Disease Areas of High Disease Risk	6
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes	6
Multiple imputation approaches for handling incomplete three‐level data with time‐varying cluster‐memberships	6
	6
Approximate likelihood‐based estimation method of multiple‐type pathogen interactions: An application to longitudinal pneumococcal carriage data	6
Measurement errors in control risk regression: A comparison of correction techniques	6
Synthesizing external aggregated information in the penalized Cox regression under population heterogeneity	6
Using a mixed‐effect model with a parameter‐space of heterogenous dimension to evaluate whether accountable care organizations are associated with greater uniformity across constituent practices	6
Fitting additive risk models using auxiliary information	6
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease	6
Fusing trial data for treatment comparisons: Single vs multi‐span bridging	6
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method	6
	6
Profile‐likelihood Bayesian model averaging for two‐sample summary data Mendelian randomization in the presence of horizontal pleiotropy	6
Properties of the full random‐effect modeling approach with missing covariate data	6
Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors	6
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis	6
Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling	6
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial	6
	6
A conditional autoregressive model for genetic association analysis accounting for genetic heterogeneity	6
Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications	6
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo	6
Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation	6
Robust analysis of cancer heterogeneity for high‐dimensional data	6
Penalized maximum likelihood inference under the mixture cure model in sparse data	6
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables	6
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data	6
Issue Information	6
Allocation in platform trials to maintain comparability across time and eligibility	6
Improving the Effectiveness of Sample Size Re‐Estimation: An Operating Characteristic Focused, Hybrid Frequentist‐Bayesian Approach	5
Robust group variable screening based on maximum Lq‐likelihood estimation	5
Spatial modeling of epidermal nerve fiber patterns	5
Issue Information	5
Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities	5
Individualized empirical null estimation for exact tests of healthcare quality	5
Issues with the expected information matrix of linear mixed models provided by popular statistical packages under missingness at random dropout	5
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study	5
Correction to “DL 101: Basic Introduction to Deep Learning With Its Application in Biomedical Related Fields”	5
A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry Data	5
Bayesian spatial models for voxel‐wise prostate cancer classification using multi‐parametric magnetic resonance imaging data	5
Two‐stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis	5
Cluster randomized trial designs for modeling time‐varying intervention effects	5
Nonparametric estimation of marked survival data in the presence of dependent censoring	5
Comparisons of statistical methods for handling attrition in a follow‐up visit with complex survey sampling	5
Event‐specific win ratios for inference with terminal and non‐terminal events	5
Estimating Mean Viral Load Trajectory From Intermittent Longitudinal Data and Unknown Time Origins	5
	5
Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances	5
Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model	5
Overall assessment for selected markers from high‐throughput data	5
New late‐emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials	5
Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation	5
Testing a global null hypothesis using ensemble machine learning methods	5